In the initial stage of AD, taking place 5–10 years before dementia diagnosis, a sharp increase in Aβ42 levels can be detected, while phospho-tau levels in cerebrospinal fluid rise more gradually [23,24]. This evidence concerns the gene MAPT and Alzheimer disease.